IL115826A - Pharmaceutical composition comprising erythropoietin for the treatment of rheumatoid arthritis - Google Patents

Pharmaceutical composition comprising erythropoietin for the treatment of rheumatoid arthritis

Info

Publication number
IL115826A
IL115826A IL11582695A IL11582695A IL115826A IL 115826 A IL115826 A IL 115826A IL 11582695 A IL11582695 A IL 11582695A IL 11582695 A IL11582695 A IL 11582695A IL 115826 A IL115826 A IL 115826A
Authority
IL
Israel
Prior art keywords
treatment
rheumatoid arthritis
erythropoietin
pharmaceutical composition
epo
Prior art date
Application number
IL11582695A
Other languages
English (en)
Other versions
IL115826A0 (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL115826A0 publication Critical patent/IL115826A0/xx
Publication of IL115826A publication Critical patent/IL115826A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL11582695A 1994-11-03 1995-10-31 Pharmaceutical composition comprising erythropoietin for the treatment of rheumatoid arthritis IL115826A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94203205 1994-11-03

Publications (2)

Publication Number Publication Date
IL115826A0 IL115826A0 (en) 1996-01-19
IL115826A true IL115826A (en) 2000-07-26

Family

ID=8217342

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11582695A IL115826A (en) 1994-11-03 1995-10-31 Pharmaceutical composition comprising erythropoietin for the treatment of rheumatoid arthritis

Country Status (9)

Country Link
US (2) US7344717B1 (de)
EP (1) EP0784480B1 (de)
AT (1) ATE251912T1 (de)
AU (1) AU3817495A (de)
DE (1) DE69531952T2 (de)
ES (1) ES2206521T3 (de)
IL (1) IL115826A (de)
WO (1) WO1996014081A1 (de)
ZA (1) ZA959325B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
DE19734293A1 (de) 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
DE60131393D1 (de) * 2000-05-02 2007-12-27 Action Pharma As Verfahren zur behandlung von erkrankungen assoziiert mit akuten entzündung unter nichtischämischen zustände
RU2197986C2 (ru) * 2001-03-23 2003-02-10 Волчек Игорь Анатольевич Иммуномодулирующее средство неинъекционного применения
DE10234192B4 (de) 2002-07-26 2009-11-26 Epoplus Gmbh Co.Kg Verwendung von Erythropoetin
RU2257216C2 (ru) * 2003-06-11 2005-07-27 Ханис Александр Юрьевич Иммуномодулирующее средство риботаб
US9610444B2 (en) 2013-03-15 2017-04-04 Pacesetter, Inc. Erythropoeitin production by electrical stimulation
EP4340865A4 (de) * 2021-05-18 2025-04-02 Attias, Eyal Verwendung von erythropoietin (epo) oder erythropoiesis stimulierendem mittel (esa) zur behandlung von osteomyelitis, knocheninfektion und knochenentzündung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732889A (en) 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
US5013718A (en) * 1986-11-21 1991-05-07 Amgen, Inc. Method for treating iron overload using EPO

Also Published As

Publication number Publication date
WO1996014081A1 (en) 1996-05-17
EP0784480A1 (de) 1997-07-23
ES2206521T3 (es) 2004-05-16
US7344717B1 (en) 2008-03-18
DE69531952D1 (de) 2003-11-20
EP0784480B1 (de) 2003-10-15
US9155782B2 (en) 2015-10-13
IL115826A0 (en) 1996-01-19
US20070249525A1 (en) 2007-10-25
DE69531952T2 (de) 2004-07-29
AU3817495A (en) 1996-05-31
ZA959325B (en) 1996-05-29
ATE251912T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
NO972451L (no) Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav
NO954342L (no) Erytropoietinanalogblandinger, samt fremgangsmåter ved fremstilling derav
EP0668750A4 (de) Pedikularschraube sowie instrumentarium für eine wirbelsäulenkorrektur von hinten.
AU7867994A (en) Hemofiltration of mediator-related diseases
AU2830097A (en) Therapeutic method for treatment of alzheimer's disease
AU1409488A (en) Coagulation treatment of fluids
FR2707882B1 (fr) Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant.
ATE257390T1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
AU2843689A (en) 2-(2-hydroxy-3-phenoxypropylamino) ethylphenoxymethyl compounds
AU563650B2 (en) Pharmaceutical compositions of benzothiophene derivatives
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
AU5229498A (en) Mutants of the lag-3 proteins, products for the expression of these mutants and use
GR3006815T3 (de)
AU2742892A (en) An anticoagulant substance obtained from urine
ZA959325B (en) Use of erythropoietin in the treatment of rheumatoid arthritis
NO972449L (no) Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav
AU570574B2 (en) Depolymerase enzymes and treatment of fireblight
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
AU3709289A (en) Strontium salt
PL322284A1 (en) Derivatives of aminoteralin useful in treating diseases of cardiovascular system
PL327168A1 (en) Pharmaceutical compositions suitable for use in treatment of diseases associated with venal lesions and/or inflammatore oedema and novel compounds used in such compositions
AU644500B2 (en) 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma
AU4819993A (en) Drug for treatment and prophylaxis of bone and joint diseases
ITRM940751A0 (it) Metodo per la realizzazione semi-industriale di calzature ortopediche personalizzate e forme componibili per l'attuazione dello stesso.
FR2743495B3 (fr) Composition cosmetique, pharmaceutique, dietetique et alimentaire et procede pour la preparation d'une telle composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired